Abstract
The new water soluble ruthenium complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane) were synthesised and characterised. Their evaluation as regioselective catalysts for hydrogenation of unsaturated ketones in aqueous biphasic conditions and as cytotoxic agents towards the TS/A adenocarcinoma cell line is briefly presented.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Catalysis
-
Cell Division / drug effects
-
Hydrogenation
-
Mice
-
Organometallic Compounds / chemical synthesis*
-
Organometallic Compounds / pharmacology
-
Ruthenium / chemistry*
-
Ruthenium / pharmacology
-
Solubility
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
Organometallic Compounds
-
Ruthenium